molecalculator

Moles & Molar Mass

Sub Q Heparin Half Life: Duration, Dosing, and Clearance

Calculator No. 01-7121 · Updated · Formula and assumptions shown below

The calculator on this page is switched off while it is checked. The formula is below, and the worked example shows how to do the sum by hand.

For study and lab planning. The result follows from the numbers you enter and the formula shown. Check it against your method before you weigh, mix or dilute anything, follow the safety data sheet and your supervisor, and do not use it for clinical, dosing or medication work.

Subcutaneous (sub q) heparin has a half-life of approximately 1.5 to 2 hours, meaning that after an injection, about half of the drug is cleared from the bloodstream within that time. This short half-life is why it is typically dosed every 8 to 12 hours for therapeutic anticoagulation, and it also means that most of the drug is gone from the body within 8 to 10 hours after the last dose.

Formula

The elimination of heparin follows first-order kinetics, meaning a constant fraction of the drug is cleared per unit time. The half-life (t1/2) is the time it takes for the plasma concentration to drop by 50%. The fraction remaining after time t is given by:

Fraction remaining = 0.5(t / t1/2)

To find the time until only 10% remains, rearrange: t = t1/2 × log(0.10) / log(0.5) = t1/2 × 3.32. The calculator above uses these formulas. You enter the half-life (default 2 hours) and the dose in units; the first output shows the time until 10% of the dose remains, and the second shows the percentage remaining after 8 hours.

Worked Example

Using the default values: half-life = 2 hours, dose = 5000 units.

  • Time to 10% remaining = 2 × log(10) / log(2) = 2 × 3.3219 = 6.64 hours.
  • Percent remaining after 8 hours = 100 × 0.5(8/2) = 100 × 0.54 = 100 × 0.0625 = 6.25%.

So after 8 hours, about 6% of the initial dose remains, which is why heparin is usually given every 8 to 12 hours to maintain a continuous anticoagulant effect.

Assumptions

  • First-order elimination kinetics (constant fraction cleared per hour).
  • Half-life is constant and does not depend on dose (true for therapeutic doses, but prolonged at high doses).
  • No organ dysfunction that would slow clearance (renal or hepatic impairment can prolong half-life).
  • The calculation is for pharmacokinetic understanding, not for clinical dosing decisions.

What Is Subcutaneous Heparin?

Heparin is a naturally occurring anticoagulant that works by binding to antithrombin III, a protein that inactivates clotting factors (especially thrombin and factor Xa). When injected subcutaneously (into the fatty layer under the skin), heparin is absorbed slowly into the bloodstream, giving a more prolonged effect than intravenous administration. The subcutaneous route is commonly used for prophylaxis of deep vein thrombosis (DVT) in hospitalized patients, and for outpatient anticoagulation when oral agents are not suitable.

How the Half-Life Is Measured

The half-life of heparin is typically measured by drawing blood samples at intervals after a dose and measuring the anti-Xa activity (or aPTT, activated partial thromboplastin time). The decline in activity over time is plotted, and the half-life is calculated from the slope. In healthy individuals, the half-life is about 1.5 hours after intravenous injection, but after subcutaneous injection, the absorption phase extends the apparent half-life to about 2 to 3 hours because the drug continues to enter the bloodstream from the injection site. This is called “flip-flop” kinetics, where absorption is slower than elimination.

Factors That Affect the Half-Life

  • Dose: Higher doses of heparin saturate clearance mechanisms, prolonging the half-life. For example, a dose of 100 units/kg may have a half-life of 1 hour, while a dose of 400 units/kg may have a half-life of 2.5 hours.
  • Liver function: Heparin is metabolized in the liver (by heparinase) and the reticuloendothelial system. Liver disease can prolong the half-life.
  • Kidney function: Although heparin is not primarily excreted by the kidneys, renal impairment can reduce clearance of the drug, especially at higher doses.
  • Age: Older adults may have reduced clearance and a longer half-life.
  • Pregnancy: Heparin does not cross the placenta, but pregnancy can alter its pharmacokinetics, sometimes requiring higher doses.

Why Short Half-Life Matters in Practice

The short half-life of subcutaneous heparin has both advantages and disadvantages. The main advantage is that if bleeding occurs, the anticoagulant effect can be reversed quickly by stopping the drug and, if needed, giving protamine sulfate. The disadvantage is that the effect wears off quickly, so dosing must be frequent to maintain therapeutic levels. For prophylaxis (preventing clots), a fixed low dose (e.g., 5000 units) is given every 8 to 12 hours. For treatment of existing clots, higher weight-based doses are given, and the aPTT is monitored to adjust the dose.

Comparing Subcutaneous Heparin to LMWH

Low-molecular-weight heparins (LMWHs) like enoxaparin are derived from heparin but have a longer half-life (about 4 to 6 hours) and more predictable pharmacokinetics. This allows once- or twice-daily dosing without routine monitoring. In contrast, unfractionated heparin (UFH) requires monitoring of aPTT when used therapeutically. The choice between the two depends on the clinical situation: UFH is preferred when rapid reversal is needed (e.g., during surgery), while LMWH is more convenient for outpatient treatment.

Common Misconception: Does Sub Q Heparin Accumulate?

A common question is whether repeated subcutaneous injections lead to accumulation of the drug. Because the half-life is short (about 2 hours), and the dosing interval is 8 to 12 hours, the drug does not accumulate significantly. After 4 to 5 half-lives (8 to 10 hours), over 95% of the drug is cleared. So, with standard dosing, there is no clinically significant accumulation. However, in patients with renal or hepatic impairment, the half-life may be prolonged, and accumulation can occur, increasing bleeding risk.

Frequently Asked Questions

How long does subcutaneous heparin stay in your system?

Heparin is eliminated from the body in about 4 to 5 half-lives. With a half-life of 2 hours, it takes roughly 8 to 10 hours for the drug to be essentially gone (less than 5% remaining). However, the anticoagulant effect may be monitored by aPTT, which usually returns to normal within 4 to 6 hours after a subcutaneous dose.

Can you give subcutaneous heparin every 12 hours?

Yes, for prophylaxis, a fixed dose of 5000 units every 12 hours is common in low-risk patients. For higher-risk patients or for therapeutic purposes, every 8 hours may be used. The dosing interval is chosen to maintain a continuous anticoagulant effect while minimizing bleeding risk.

What is the difference between half-life and duration of action?

Half-life is the time for the drug concentration in the blood to fall by half. Duration of action is how long the drug has a measurable effect. For heparin, the effect on clotting (measured by aPTT) lasts slightly longer than the half-life because the drug binds to antithrombin and the effect persists even after free drug is cleared. Typically, the anticoagulant effect lasts 4 to 6 hours after a subcutaneous dose.

Does food affect the absorption of subcutaneous heparin?

No, subcutaneous heparin is injected into the fatty tissue, so food does not affect its absorption. However, injection site rotation (abdomen, thigh, arm) is important to avoid bruising and lipohypertrophy. The abdomen is preferred because it provides consistent absorption.

Can a patient with kidney disease use subcutaneous heparin?

Unfractionated heparin is often preferred in patients with severe renal impairment because it is not primarily cleared by the kidneys and its effect can be easily monitored and reversed. However, the half-life may be slightly prolonged, so monitoring of aPTT is recommended. LMWHs are usually avoided in severe renal impairment because they accumulate.

How do you calculate the time to zero?

Strictly speaking, first-order kinetics never reaches zero; it asymptotically approaches zero. In practice, after 5 half-lives, about 97% of the drug is eliminated, and after 7 half-lives, over 99% is gone. So, for a 2-hour half-life, the drug is considered effectively eliminated after about 14 hours.

Remember, this information is for educational purposes. Always follow your healthcare provider’s instructions and the medication guide for heparin.

Related

Formula used
in h | Half-life (hours) | h | 2 | 0.1
in d | Dose (units) | units | 5000 | 0
out t | Time to 10% remaining (hours) | h | h * log(10) / log(2) | 2
out r | Percent remaining after 8 hours | % | 100 * 0.5^(8 / h) | 2

Each line is one input (in, sel, list) or one result (out: label, unit, formula, decimals). How the calculators work

Method: the standard formula for this calculation with the constants and conversion factors written on the page, rounded as each result states. See method and constants, the disclaimer or report an error.

More in this section

The whole Moles & Molar Mass section →